Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Bipolar Disorder | 148 | 2024 | 5128 | 10.200 |
Why?
|
Lithium | 37 | 2024 | 599 | 4.520 |
Why?
|
Depressive Disorder, Major | 44 | 2024 | 4809 | 3.920 |
Why?
|
Suicide, Attempted | 35 | 2024 | 1413 | 2.990 |
Why?
|
Lithium Compounds | 20 | 2024 | 226 | 2.840 |
Why?
|
Antimanic Agents | 30 | 2024 | 523 | 2.840 |
Why?
|
Suicide | 28 | 2023 | 1606 | 2.800 |
Why?
|
Antidepressive Agents | 49 | 2024 | 2901 | 2.760 |
Why?
|
Mood Disorders | 19 | 2023 | 1127 | 2.640 |
Why?
|
Temperament | 15 | 2024 | 300 | 2.550 |
Why?
|
Suicidal Ideation | 12 | 2024 | 1466 | 1.670 |
Why?
|
Italy | 26 | 2021 | 851 | 1.310 |
Why?
|
Psychotropic Drugs | 7 | 2022 | 880 | 1.160 |
Why?
|
Lithium Carbonate | 12 | 2010 | 179 | 1.050 |
Why?
|
Depressive Disorder | 22 | 2020 | 3712 | 1.030 |
Why?
|
Antipsychotic Agents | 16 | 2024 | 3077 | 1.030 |
Why?
|
Anxiety Disorders | 11 | 2022 | 2741 | 0.910 |
Why?
|
Cyclothymic Disorder | 3 | 2014 | 42 | 0.840 |
Why?
|
Electroconvulsive Therapy | 7 | 2016 | 505 | 0.810 |
Why?
|
Diagnostic and Statistical Manual of Mental Disorders | 12 | 2023 | 1988 | 0.680 |
Why?
|
Appetite | 1 | 2022 | 247 | 0.670 |
Why?
|
Depression | 16 | 2022 | 8230 | 0.660 |
Why?
|
Age of Onset | 15 | 2023 | 3344 | 0.600 |
Why?
|
Psychopharmacology | 1 | 2019 | 146 | 0.560 |
Why?
|
Psychiatry | 4 | 2018 | 1715 | 0.560 |
Why?
|
Transients and Migrants | 1 | 2020 | 170 | 0.550 |
Why?
|
Anticonvulsants | 9 | 2024 | 1920 | 0.540 |
Why?
|
Humans | 202 | 2024 | 766117 | 0.540 |
Why?
|
Antidepressive Agents, Tricyclic | 3 | 2020 | 427 | 0.530 |
Why?
|
Resilience, Psychological | 1 | 2024 | 808 | 0.530 |
Why?
|
Argentina | 7 | 2020 | 249 | 0.520 |
Why?
|
Adult | 93 | 2024 | 223139 | 0.480 |
Why?
|
Psychotic Disorders | 6 | 2018 | 3274 | 0.450 |
Why?
|
Adaptation, Psychological | 2 | 2024 | 2662 | 0.440 |
Why?
|
Menarche | 1 | 2016 | 532 | 0.440 |
Why?
|
Drug Therapy | 1 | 2016 | 504 | 0.430 |
Why?
|
Borderline Personality Disorder | 1 | 2020 | 767 | 0.410 |
Why?
|
Risk Factors | 43 | 2024 | 74857 | 0.410 |
Why?
|
Personality Inventory | 6 | 2022 | 1019 | 0.400 |
Why?
|
Micronutrients | 1 | 2015 | 390 | 0.400 |
Why?
|
Psychiatric Status Rating Scales | 16 | 2023 | 6020 | 0.390 |
Why?
|
Female | 109 | 2024 | 396233 | 0.380 |
Why?
|
Weight Gain | 1 | 2022 | 2356 | 0.380 |
Why?
|
Male | 105 | 2024 | 363935 | 0.370 |
Why?
|
Internationality | 5 | 2019 | 1007 | 0.370 |
Why?
|
Reproductive Behavior | 1 | 2011 | 27 | 0.360 |
Why?
|
Emigrants and Immigrants | 1 | 2017 | 550 | 0.350 |
Why?
|
Substance Withdrawal Syndrome | 10 | 2010 | 627 | 0.330 |
Why?
|
Birth Rate | 1 | 2011 | 168 | 0.330 |
Why?
|
Irritable Mood | 3 | 2021 | 196 | 0.320 |
Why?
|
Siblings | 1 | 2013 | 828 | 0.320 |
Why?
|
Selection, Genetic | 1 | 2013 | 877 | 0.310 |
Why?
|
Mental Disorders | 4 | 2019 | 6871 | 0.310 |
Why?
|
Treatment Outcome | 41 | 2024 | 65219 | 0.300 |
Why?
|
Seasons | 5 | 2022 | 1522 | 0.290 |
Why?
|
Sex Distribution | 4 | 2020 | 2270 | 0.290 |
Why?
|
Middle Aged | 58 | 2024 | 223083 | 0.290 |
Why?
|
Multivariate Analysis | 8 | 2015 | 12061 | 0.280 |
Why?
|
Sex Factors | 19 | 2019 | 10614 | 0.280 |
Why?
|
Prevalence | 14 | 2023 | 15827 | 0.280 |
Why?
|
Comorbidity | 11 | 2018 | 10579 | 0.260 |
Why?
|
Puerperal Disorders | 3 | 2023 | 304 | 0.260 |
Why?
|
Dysthymic Disorder | 2 | 2024 | 73 | 0.250 |
Why?
|
Age Distribution | 3 | 2020 | 2865 | 0.250 |
Why?
|
Family Characteristics | 1 | 2011 | 1001 | 0.250 |
Why?
|
History, 19th Century | 3 | 2018 | 711 | 0.240 |
Why?
|
Attention Deficit Disorder with Hyperactivity | 3 | 2018 | 3719 | 0.230 |
Why?
|
Health Personnel | 1 | 2018 | 3387 | 0.230 |
Why?
|
Substance-Related Disorders | 8 | 2019 | 4418 | 0.220 |
Why?
|
Sunlight | 3 | 2022 | 335 | 0.210 |
Why?
|
Drug Therapy, Combination | 12 | 2021 | 6309 | 0.210 |
Why?
|
Cross-Cultural Comparison | 3 | 2020 | 636 | 0.210 |
Why?
|
Morbidity | 4 | 2021 | 1753 | 0.210 |
Why?
|
Affect | 3 | 2024 | 1494 | 0.210 |
Why?
|
Anxiety | 4 | 2022 | 4672 | 0.210 |
Why?
|
Drug Administration Schedule | 14 | 2010 | 4853 | 0.200 |
Why?
|
Recurrence | 23 | 2015 | 8494 | 0.190 |
Why?
|
Clinical Trials as Topic | 6 | 2014 | 8038 | 0.180 |
Why?
|
Valproic Acid | 2 | 2021 | 444 | 0.180 |
Why?
|
History, 20th Century | 4 | 2018 | 2762 | 0.180 |
Why?
|
Survival Analysis | 10 | 2022 | 10087 | 0.160 |
Why?
|
Randomized Controlled Trials as Topic | 13 | 2022 | 10380 | 0.160 |
Why?
|
Schizophrenia | 3 | 2015 | 6975 | 0.150 |
Why?
|
History, Medieval | 1 | 2018 | 62 | 0.150 |
Why?
|
Severity of Illness Index | 10 | 2020 | 15882 | 0.150 |
Why?
|
Paranoid Disorders | 1 | 2018 | 61 | 0.150 |
Why?
|
History, 17th Century | 1 | 2018 | 108 | 0.150 |
Why?
|
Scopolamine | 3 | 1997 | 92 | 0.140 |
Why?
|
Schizophrenia, Paranoid | 1 | 2018 | 102 | 0.140 |
Why?
|
History, Ancient | 1 | 2018 | 213 | 0.140 |
Why?
|
Time Factors | 22 | 2024 | 40108 | 0.140 |
Why?
|
Cities | 1 | 2020 | 542 | 0.140 |
Why?
|
Age Factors | 10 | 2019 | 18386 | 0.140 |
Why?
|
Interview, Psychological | 2 | 2011 | 811 | 0.140 |
Why?
|
Demography | 2 | 2015 | 1641 | 0.140 |
Why?
|
Medication Adherence | 1 | 2008 | 2190 | 0.140 |
Why?
|
History, 18th Century | 1 | 2017 | 206 | 0.130 |
Why?
|
Self-Help Groups | 1 | 2017 | 194 | 0.130 |
Why?
|
Brazil | 1 | 2020 | 1248 | 0.120 |
Why?
|
Benzodiazepines | 3 | 2021 | 1136 | 0.120 |
Why?
|
Delusions | 1 | 2018 | 300 | 0.120 |
Why?
|
Adolescent | 18 | 2023 | 88819 | 0.120 |
Why?
|
Longitudinal Studies | 8 | 2022 | 14747 | 0.120 |
Why?
|
Psychometrics | 7 | 2018 | 3060 | 0.120 |
Why?
|
Ketamine | 2 | 2021 | 527 | 0.120 |
Why?
|
Behavioral Symptoms | 1 | 2016 | 187 | 0.120 |
Why?
|
Internet | 2 | 2017 | 3107 | 0.120 |
Why?
|
Personality | 2 | 2011 | 559 | 0.110 |
Why?
|
Follow-Up Studies | 16 | 2018 | 39243 | 0.110 |
Why?
|
Logistic Models | 4 | 2018 | 13273 | 0.110 |
Why?
|
MMPI | 2 | 1991 | 80 | 0.110 |
Why?
|
Memantine | 1 | 2015 | 110 | 0.110 |
Why?
|
Circadian Rhythm | 4 | 2022 | 2594 | 0.110 |
Why?
|
Secondary Prevention | 7 | 2010 | 1470 | 0.110 |
Why?
|
Patient Dropouts | 2 | 2014 | 411 | 0.110 |
Why?
|
Thyrotropin-Releasing Hormone | 1 | 1993 | 139 | 0.110 |
Why?
|
Controlled Clinical Trials as Topic | 1 | 2014 | 187 | 0.110 |
Why?
|
Imipramine | 1 | 2012 | 96 | 0.100 |
Why?
|
Probiotics | 1 | 2017 | 387 | 0.100 |
Why?
|
Risk Adjustment | 1 | 2016 | 597 | 0.100 |
Why?
|
Young Adult | 10 | 2023 | 59868 | 0.100 |
Why?
|
ROC Curve | 3 | 2019 | 3614 | 0.100 |
Why?
|
Monoamine Oxidase Inhibitors | 1 | 2012 | 152 | 0.100 |
Why?
|
Excitatory Amino Acid Antagonists | 1 | 2015 | 451 | 0.100 |
Why?
|
Disease Susceptibility | 1 | 1999 | 1790 | 0.100 |
Why?
|
Personality Assessment | 2 | 2011 | 646 | 0.100 |
Why?
|
Retrospective Studies | 13 | 2022 | 81565 | 0.090 |
Why?
|
Fluoxetine | 1 | 2015 | 732 | 0.090 |
Why?
|
Family Health | 2 | 2015 | 1253 | 0.090 |
Why?
|
Ejaculation | 1 | 1991 | 59 | 0.090 |
Why?
|
Panic Disorder | 2 | 2014 | 613 | 0.090 |
Why?
|
Disease Progression | 3 | 2024 | 13616 | 0.090 |
Why?
|
Child | 12 | 2023 | 80573 | 0.090 |
Why?
|
Gene Products, rev | 1 | 2010 | 29 | 0.090 |
Why?
|
Prospective Studies | 12 | 2023 | 54812 | 0.090 |
Why?
|
Causality | 1 | 2016 | 1247 | 0.090 |
Why?
|
Nuclear Receptor Subfamily 1, Group D, Member 1 | 1 | 2010 | 33 | 0.090 |
Why?
|
Placebo Effect | 1 | 2014 | 515 | 0.080 |
Why?
|
Risk Assessment | 9 | 2014 | 24276 | 0.080 |
Why?
|
Thyrotropin | 1 | 1993 | 834 | 0.080 |
Why?
|
Sexual Dysfunctions, Psychological | 1 | 1991 | 193 | 0.080 |
Why?
|
Panic | 1 | 1989 | 103 | 0.080 |
Why?
|
Sexuality | 1 | 2011 | 179 | 0.080 |
Why?
|
Fatty Acids | 1 | 2017 | 1805 | 0.080 |
Why?
|
Phenotype | 2 | 2024 | 16716 | 0.080 |
Why?
|
Growth Hormone | 1 | 1991 | 567 | 0.080 |
Why?
|
Physician-Patient Relations | 1 | 2022 | 3270 | 0.080 |
Why?
|
Health Services Accessibility | 1 | 2006 | 5510 | 0.080 |
Why?
|
Carbamazepine | 1 | 1989 | 224 | 0.070 |
Why?
|
Europe | 4 | 2017 | 3430 | 0.070 |
Why?
|
Case-Control Studies | 2 | 2024 | 22228 | 0.070 |
Why?
|
Psychotherapy | 2 | 2023 | 1648 | 0.070 |
Why?
|
Erectile Dysfunction | 1 | 1991 | 437 | 0.070 |
Why?
|
Aged | 15 | 2020 | 171219 | 0.070 |
Why?
|
Hydrocortisone | 2 | 1993 | 1832 | 0.070 |
Why?
|
Periodicity | 3 | 2000 | 347 | 0.070 |
Why?
|
Anti-Inflammatory Agents | 1 | 2017 | 1805 | 0.070 |
Why?
|
Ecology | 1 | 2007 | 105 | 0.070 |
Why?
|
Caffeine | 1 | 1991 | 702 | 0.070 |
Why?
|
Long-Term Care | 4 | 2007 | 630 | 0.070 |
Why?
|
Citalopram | 1 | 2009 | 402 | 0.070 |
Why?
|
Cluster Analysis | 2 | 2024 | 2718 | 0.070 |
Why?
|
Antidepressive Agents, Second-Generation | 1 | 2009 | 490 | 0.070 |
Why?
|
Advisory Committees | 3 | 2015 | 796 | 0.070 |
Why?
|
Emotions | 1 | 2018 | 2758 | 0.060 |
Why?
|
Pindolol | 1 | 1985 | 34 | 0.060 |
Why?
|
Hospitalization | 4 | 2015 | 10811 | 0.060 |
Why?
|
Sleep | 2 | 1993 | 4816 | 0.060 |
Why?
|
Fertility | 1 | 2011 | 770 | 0.060 |
Why?
|
Risk | 3 | 2010 | 9599 | 0.060 |
Why?
|
Bayes Theorem | 1 | 2014 | 2353 | 0.060 |
Why?
|
Sleep, REM | 3 | 1997 | 593 | 0.060 |
Why?
|
Multicenter Studies as Topic | 1 | 2011 | 1729 | 0.060 |
Why?
|
Odds Ratio | 3 | 2010 | 9657 | 0.060 |
Why?
|
Dexamethasone | 1 | 1993 | 1962 | 0.060 |
Why?
|
Population Density | 1 | 2006 | 193 | 0.060 |
Why?
|
Psychological Tests | 1 | 1988 | 642 | 0.060 |
Why?
|
Exercise | 1 | 2022 | 5939 | 0.060 |
Why?
|
Censuses | 1 | 2006 | 197 | 0.060 |
Why?
|
Receptors, Adrenergic, beta | 1 | 1985 | 242 | 0.060 |
Why?
|
Coffee | 1 | 2009 | 593 | 0.060 |
Why?
|
Unemployment | 3 | 1991 | 211 | 0.060 |
Why?
|
Cross-Sectional Studies | 5 | 2022 | 26290 | 0.060 |
Why?
|
Calcium Channels | 1 | 2008 | 622 | 0.060 |
Why?
|
Language | 1 | 2014 | 1550 | 0.060 |
Why?
|
Postpartum Period | 1 | 2011 | 1195 | 0.060 |
Why?
|
Socioeconomic Factors | 2 | 2009 | 7843 | 0.060 |
Why?
|
Placebos | 2 | 2006 | 1659 | 0.060 |
Why?
|
Genome-Wide Association Study | 1 | 2023 | 12803 | 0.050 |
Why?
|
Stress, Psychological | 1 | 1999 | 4527 | 0.050 |
Why?
|
Pregnancy Complications | 2 | 2011 | 2970 | 0.050 |
Why?
|
Financing, Government | 1 | 2006 | 473 | 0.050 |
Why?
|
Indians, North American | 1 | 2006 | 354 | 0.050 |
Why?
|
Societies, Medical | 1 | 2014 | 3955 | 0.050 |
Why?
|
Drug Resistance | 1 | 2008 | 1592 | 0.050 |
Why?
|
Regression Analysis | 3 | 2010 | 6324 | 0.050 |
Why?
|
Residence Characteristics | 1 | 2011 | 2116 | 0.050 |
Why?
|
Meta-Analysis as Topic | 1 | 2006 | 1366 | 0.050 |
Why?
|
Medically Uninsured | 1 | 2006 | 838 | 0.040 |
Why?
|
Fear | 1 | 1989 | 1496 | 0.040 |
Why?
|
Dose-Response Relationship, Drug | 4 | 2021 | 10737 | 0.040 |
Why?
|
Pituitary-Adrenal System | 1 | 2023 | 553 | 0.040 |
Why?
|
Republic of Korea | 2 | 2011 | 591 | 0.040 |
Why?
|
Sex Offenses | 1 | 2023 | 355 | 0.040 |
Why?
|
Inpatients | 1 | 2011 | 2566 | 0.040 |
Why?
|
Prognosis | 8 | 2018 | 29912 | 0.040 |
Why?
|
Incidence | 3 | 2015 | 21513 | 0.040 |
Why?
|
Sensitivity and Specificity | 1 | 2014 | 14645 | 0.040 |
Why?
|
Hypothalamo-Hypophyseal System | 1 | 2023 | 702 | 0.040 |
Why?
|
Lebanon | 2 | 2011 | 246 | 0.040 |
Why?
|
Factor Analysis, Statistical | 2 | 2014 | 1001 | 0.040 |
Why?
|
Central Nervous System | 1 | 1985 | 1343 | 0.040 |
Why?
|
Climate | 1 | 2019 | 146 | 0.040 |
Why?
|
Health Services Needs and Demand | 1 | 2006 | 1404 | 0.040 |
Why?
|
Solar System | 1 | 2017 | 12 | 0.040 |
Why?
|
Aggression | 1 | 2022 | 747 | 0.040 |
Why?
|
Personality Disorders | 2 | 2014 | 727 | 0.040 |
Why?
|
Electroencephalography | 1 | 1993 | 6279 | 0.040 |
Why?
|
Cause of Death | 2 | 2006 | 3715 | 0.040 |
Why?
|
Hospitals, Psychiatric | 1 | 1999 | 318 | 0.040 |
Why?
|
Income | 1 | 2006 | 1874 | 0.030 |
Why?
|
South America | 1 | 2017 | 180 | 0.030 |
Why?
|
Sleep Stages | 2 | 1993 | 705 | 0.030 |
Why?
|
Muscarinic Antagonists | 1 | 1997 | 135 | 0.030 |
Why?
|
Receptors, Cholinergic | 1 | 1997 | 243 | 0.030 |
Why?
|
Asia | 1 | 2017 | 630 | 0.030 |
Why?
|
Area Under Curve | 1 | 2019 | 1638 | 0.030 |
Why?
|
Quality of Life | 1 | 2017 | 13468 | 0.030 |
Why?
|
Preventive Psychiatry | 1 | 2014 | 6 | 0.030 |
Why?
|
Models, Statistical | 1 | 2009 | 5089 | 0.030 |
Why?
|
Africa | 1 | 2017 | 726 | 0.030 |
Why?
|
Epilepsy | 1 | 2010 | 3317 | 0.030 |
Why?
|
Partial Thromboplastin Time | 1 | 1994 | 203 | 0.030 |
Why?
|
North America | 1 | 2017 | 1287 | 0.030 |
Why?
|
Australia | 1 | 2017 | 1260 | 0.030 |
Why?
|
Urban Population | 1 | 2021 | 2040 | 0.030 |
Why?
|
Greece | 1 | 2014 | 341 | 0.030 |
Why?
|
Seasonal Affective Disorder | 1 | 1993 | 49 | 0.030 |
Why?
|
Crime | 1 | 2014 | 206 | 0.030 |
Why?
|
Episode of Care | 1 | 2013 | 127 | 0.030 |
Why?
|
Health Care Costs | 1 | 2006 | 3243 | 0.030 |
Why?
|
Smoking | 1 | 2009 | 9082 | 0.030 |
Why?
|
Syndrome | 1 | 1999 | 3270 | 0.020 |
Why?
|
United States | 5 | 2011 | 72920 | 0.020 |
Why?
|
Impulsive Behavior | 1 | 2014 | 345 | 0.020 |
Why?
|
Chlorpromazine | 1 | 1991 | 111 | 0.020 |
Why?
|
Personality Development | 1 | 1991 | 241 | 0.020 |
Why?
|
Spain | 1 | 2011 | 483 | 0.020 |
Why?
|
Health Surveys | 2 | 2011 | 4058 | 0.020 |
Why?
|
Overweight | 1 | 2021 | 2444 | 0.020 |
Why?
|
Reference Standards | 1 | 2014 | 1011 | 0.020 |
Why?
|
Sleep Initiation and Maintenance Disorders | 1 | 2019 | 1102 | 0.020 |
Why?
|
Reproducibility of Results | 4 | 2014 | 20137 | 0.020 |
Why?
|
Pregnancy | 4 | 2011 | 30233 | 0.020 |
Why?
|
Cohort Studies | 2 | 2009 | 41684 | 0.020 |
Why?
|
Haloperidol | 1 | 1991 | 394 | 0.020 |
Why?
|
Delphi Technique | 1 | 2013 | 893 | 0.020 |
Why?
|
Brain | 2 | 2015 | 27177 | 0.020 |
Why?
|
Agoraphobia | 1 | 1989 | 177 | 0.020 |
Why?
|
Drug Combinations | 1 | 2015 | 2076 | 0.020 |
Why?
|
France | 1 | 2010 | 495 | 0.020 |
Why?
|
Research Design | 2 | 2004 | 6206 | 0.020 |
Why?
|
Patient Care Planning | 1 | 2013 | 903 | 0.020 |
Why?
|
Delivery of Health Care | 1 | 2006 | 5367 | 0.020 |
Why?
|
International Cooperation | 1 | 2014 | 1433 | 0.020 |
Why?
|
Patient Selection | 1 | 2000 | 4249 | 0.020 |
Why?
|
Rome | 1 | 2007 | 27 | 0.020 |
Why?
|
Physicians | 1 | 2006 | 4591 | 0.020 |
Why?
|
Reaction Time | 2 | 1997 | 2086 | 0.020 |
Why?
|
Medical Records Systems, Computerized | 1 | 2013 | 1195 | 0.020 |
Why?
|
Translations | 1 | 2007 | 84 | 0.020 |
Why?
|
Pharmacoepidemiology | 1 | 2010 | 351 | 0.020 |
Why?
|
Betaxolol | 1 | 1985 | 1 | 0.020 |
Why?
|
Alprenolol | 1 | 1985 | 8 | 0.020 |
Why?
|
Clenbuterol | 1 | 1985 | 9 | 0.020 |
Why?
|
Propanolamines | 1 | 1985 | 163 | 0.020 |
Why?
|
Peer Review | 1 | 2007 | 217 | 0.020 |
Why?
|
Diagnosis, Dual (Psychiatry) | 1 | 2005 | 300 | 0.010 |
Why?
|
Congresses as Topic | 1 | 2010 | 811 | 0.010 |
Why?
|
Infusions, Intravenous | 1 | 2009 | 2227 | 0.010 |
Why?
|
Self Report | 1 | 2016 | 3769 | 0.010 |
Why?
|
Genotype | 2 | 2010 | 13028 | 0.010 |
Why?
|
Outpatients | 1 | 2012 | 1596 | 0.010 |
Why?
|
Principal Component Analysis | 1 | 2007 | 947 | 0.010 |
Why?
|
Rats, Inbred Strains | 1 | 1985 | 2077 | 0.010 |
Why?
|
Mathematics | 1 | 1985 | 696 | 0.010 |
Why?
|
Binding, Competitive | 1 | 1985 | 1140 | 0.010 |
Why?
|
Isotope Labeling | 1 | 1985 | 390 | 0.010 |
Why?
|
Linear Models | 1 | 2014 | 5873 | 0.010 |
Why?
|
Propranolol | 1 | 1985 | 494 | 0.010 |
Why?
|
Drug Approval | 1 | 2011 | 820 | 0.010 |
Why?
|
Cooperative Behavior | 1 | 2011 | 1512 | 0.010 |
Why?
|
Genetic Markers | 1 | 2010 | 2603 | 0.010 |
Why?
|
Statistics, Nonparametric | 1 | 2009 | 2844 | 0.010 |
Why?
|
Consensus | 1 | 2013 | 3202 | 0.010 |
Why?
|
International Classification of Diseases | 1 | 2009 | 934 | 0.010 |
Why?
|
Chi-Square Distribution | 1 | 2009 | 3432 | 0.010 |
Why?
|
Linkage Disequilibrium | 1 | 2008 | 1996 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 2 | 2018 | 18076 | 0.010 |
Why?
|
Analysis of Variance | 1 | 1991 | 6208 | 0.010 |
Why?
|
Statistics as Topic | 1 | 2009 | 2351 | 0.010 |
Why?
|
Liver Transplantation | 1 | 1994 | 2417 | 0.010 |
Why?
|
Checklist | 1 | 2009 | 841 | 0.010 |
Why?
|
Patient Admission | 1 | 2009 | 1365 | 0.010 |
Why?
|
Tissue Distribution | 1 | 1985 | 2271 | 0.010 |
Why?
|
Administration, Oral | 1 | 2009 | 4016 | 0.010 |
Why?
|
Proportional Hazards Models | 2 | 2010 | 12529 | 0.010 |
Why?
|
Employment | 1 | 1987 | 1108 | 0.010 |
Why?
|
Confidence Intervals | 1 | 2006 | 2915 | 0.010 |
Why?
|
Sex Characteristics | 1 | 2011 | 2646 | 0.010 |
Why?
|
Brain Stem | 1 | 1985 | 852 | 0.010 |
Why?
|
Animals | 3 | 2021 | 168800 | 0.010 |
Why?
|
Polymorphism, Genetic | 1 | 2010 | 4249 | 0.010 |
Why?
|
Alleles | 1 | 2010 | 6892 | 0.010 |
Why?
|
Cerebellum | 1 | 1985 | 1519 | 0.010 |
Why?
|
Spinal Cord | 1 | 1985 | 1811 | 0.010 |
Why?
|
Databases, Factual | 1 | 2013 | 8062 | 0.010 |
Why?
|
Gene Expression | 1 | 2008 | 7582 | 0.010 |
Why?
|
Genetic Variation | 1 | 2010 | 6612 | 0.010 |
Why?
|
Affective Symptoms | 1 | 1976 | 418 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2008 | 12775 | 0.010 |
Why?
|
Informed Consent | 1 | 1999 | 1010 | 0.010 |
Why?
|
Polysomnography | 1 | 1997 | 1868 | 0.010 |
Why?
|
Postoperative Period | 1 | 1994 | 1820 | 0.010 |
Why?
|
Cerebral Cortex | 1 | 1985 | 5758 | 0.010 |
Why?
|
Rats | 1 | 1985 | 23717 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2008 | 16040 | 0.000 |
Why?
|
Receptors, Muscarinic | 1 | 1989 | 156 | 0.000 |
Why?
|
Probability | 1 | 1993 | 2475 | 0.000 |
Why?
|
Hypochondriasis | 1 | 1987 | 93 | 0.000 |
Why?
|
Erythrocytes | 1 | 1976 | 2394 | 0.000 |
Why?
|
Terminology as Topic | 1 | 1993 | 1536 | 0.000 |
Why?
|
Predictive Value of Tests | 1 | 2000 | 15403 | 0.000 |
Why?
|
Double-Blind Method | 1 | 1997 | 12426 | 0.000 |
Why?
|
Aged, 80 and over | 1 | 2008 | 59515 | 0.000 |
Why?
|
Ambulatory Care | 1 | 1993 | 2778 | 0.000 |
Why?
|
Diagnosis, Differential | 1 | 1993 | 12976 | 0.000 |
Why?
|
Remission, Spontaneous | 1 | 1977 | 384 | 0.000 |
Why?
|
Drug Interactions | 1 | 1981 | 1419 | 0.000 |
Why?
|
Functional Laterality | 1 | 1977 | 2244 | 0.000 |
Why?
|